Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Change in Cash (2010 - 2026)

Vericel (VCEL) posted Change in Cash of $16.1 million for Q2 2026, up 74.54% sequentially from $9.2 million in Q1 2026, and up 1842.32% YoY from $827000.0 in Q2 2025.

Analysis

Vericel (VCEL) Change in Cash (2010 - 2026) Analysis & Trends

Vericel has reported Change in Cash for 17 years, with the latest figure at $16.1 million in Q2 2026.

  • Quarterly Change in Cash rose 1842.32% year-over-year to $16.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $44.8 million (up 858.23% YoY) and the FY2025 annual result came in at $15.0 million, up 927.9% from the prior year.
  • Change in Cash advanced to $16.1 million in Q2 2026 per VCEL's latest filing, from $9.2 million in the prior quarter.
  • Over five years, Change in Cash peaked at $19.9 million in Q3 2025 and troughed at -$16.1 million in Q1 2024.
  • A 5-year average of $3.2 million and a median of $3.1 million in 2022 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash soared 2174.18% in 2023, then plunged 249.75% in 2024.
  • Over 5 years, Change in Cash stood at -$14.1 million in 2022, then jumped by 123.36% to $3.3 million in 2023, then surged by 344.75% to $14.7 million in 2024, then slumped by 102.12% to -$311000.0 in 2025, then soared by 5264.95% to $16.1 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered $16.1 million, $9.2 million, and -$311000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 16.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.06 Mn
Mar 31, 2026 9.20 Mn
Dec 31, 2025 -311,000.00
Sep 30, 2025 19.87 Mn
Jun 30, 2025 827,000.00
Mar 31, 2025 -5.34 Mn
Dec 31, 2024 14.70 Mn
Sep 30, 2024 -5.50 Mn
Jun 30, 2024 5.11 Mn
Mar 31, 2024 -16.12 Mn
Dec 31, 2023 3.31 Mn
Sep 30, 2023 12.74 Mn
Jun 30, 2023 8.98 Mn
Mar 31, 2023 10.77 Mn
Dec 31, 2022 -14.15 Mn
Sep 30, 2022 2.98 Mn
Jun 30, 2022 395,000.00
Mar 31, 2022 -6.70 Mn
Dec 31, 2021 13.78 Mn
Sep 30, 2021 2.79 Mn